Biodex Training in Hemodialysis Females With Osteopenia

Hemolysis Clinical Trial

Official title:

Balance Response to Biodex Training in Hemodialysis Females With Osteopenia

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT06223802
• Other study ID #: P.T.REC/012/004928
• Status: Recruiting
• Phase: N/A
• Start date: November 8, 2023
• Est. completion date: March 8, 2024

Study information

• Verified date: January 2024
• Source: Ahram Canadian University
• Contact: hagar El-Hadidy, lecturer
• Phone: 01007453552
• Email: hagarhadidy2016[@]gmail.com
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

imbalance is a common problem in hemodialysis patients with osteopneia, biodex training is a good device that treat imbalance

Description:

58 women with osteopenia problem and dialysis will be divided to trained women group with a number of 29 women receiving 3-time biodex training per week, every time will be 10 minutes for 12 weeks or nontrained women group that will act as a control group (n = 29 women)

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 58
• Est. completion date: March 8, 2024
• Est. primary completion date: March 8, 2024
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 35 Years to 45 Years

Eligibility

Inclusion Criteria:

• osteopneia women
• hemodialysis women

Exclusion Criteria:

• pregnancy
• autoimmune disorders
• lower limb orthopedic problems
• psychological manifestaion

Related Conditions & MeSH terms

• Bone Diseases, Metabolic
• Hemolysis

Intervention

Behavioral:
• biodex training
women group with a number of 29 women receiving 3-time biodex training per week, every time will be 10 minutes for 12 weeks

Locations

Country	Name	City	State
Egypt	Ahram canadian university	Giza

Sponsors (1)

Lead Sponsor	Collaborator
Ahram Canadian University

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	bone mineral density of femur bone	it will be measured by DEXA	it will be measured after 12 weeks
Secondary	overall stability index	it a parameter indicates the good balance of patients	it will be measured after 12 weeks
Secondary	Antero posterior stability index	it a parameter indicates the good balance of patients	it will be measured after 12 weeks
Secondary	Mediolateral stability index	it a parameter indicates the good balance of patients	it will be measured after 12 weeks
Secondary	six minute walk test	it a parameter asses funntional capacity	it will be measured after 12 weeks
Secondary	Short physical performance battery	total score or points will be assessed from this physical performance test	it will be measured after 12 weeks